Biocartis Group Toekomstige groei
Future criteriumcontroles 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Biocartis Group.
Belangrijke informatie
n/a
Groei van de winst
n/a
Groei van de winst per aandeel
Medical Equipment winstgroei | 19.0% |
Inkomstengroei | n/a |
Toekomstig rendement op eigen vermogen | n/a |
Dekking van analisten | None |
Laatst bijgewerkt | n/a |
Recente toekomstige groei-updates
Recent updates
Investors Give Biocartis Group NV (EBR:BCART) Shares A 31% Hiding
Jun 17Analysts Have Been Trimming Their Biocartis Group NV (EBR:BCART) Price Target After Its Latest Report
Feb 27We Think Biocartis Group (EBR:BCART) Has A Fair Chunk Of Debt
Mar 03What Kind Of Shareholders Own Biocartis Group NV (EBR:BCART)?
Jan 27What We Learned About Biocartis Group's (EBR:BCART) CEO Compensation
Dec 06What Can We Learn About Biocartis Group's (EBR:BCART) CEO Compensation?
Sep 01What Type Of Returns Would Biocartis Group's(EBR:BCART) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?
Jul 28In dit gedeelte presenteren we gewoonlijk prognoses voor de omzet- en winstgroei op basis van de consensusramingen van professionele analisten om beleggers te helpen begrijpen in hoeverre het bedrijf in staat is winst te genereren. Maar omdat Biocartis Group onvoldoende gegevens uit het verleden heeft verstrekt en geen analistenprognose heeft, kan de toekomstige winst niet betrouwbaar worden berekend door gegevens uit het verleden te extrapoleren of analistenprognoses te gebruiken.
Dit is een vrij zeldzame situatie, aangezien 97% van de bedrijven die worden gedekt door SimplyWall St wel financiële gegevens uit het verleden hebben.
Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
6/30/2023 | 61 | -68 | -51 | -50 | N/A |
3/31/2023 | 59 | -67 | -49 | -47 | N/A |
12/31/2022 | 58 | -65 | -47 | -45 | N/A |
9/30/2022 | 58 | -64 | -53 | -50 | N/A |
6/30/2022 | 59 | -63 | -60 | -56 | N/A |
3/31/2022 | 57 | -67 | -64 | -61 | N/A |
12/31/2021 | 55 | -71 | -69 | -66 | N/A |
9/30/2021 | 58 | -70 | -60 | -57 | N/A |
6/30/2021 | 61 | -69 | -51 | -48 | N/A |
3/31/2021 | 58 | -66 | -47 | -44 | N/A |
12/31/2020 | 56 | -63 | -42 | -39 | N/A |
9/30/2020 | 47 | -64 | -47 | -45 | N/A |
6/30/2020 | 38 | -66 | -51 | -50 | N/A |
3/31/2020 | 38 | -65 | -54 | -52 | N/A |
12/31/2019 | 38 | -64 | -57 | -54 | N/A |
9/30/2019 | 35 | -60 | -56 | -52 | N/A |
6/30/2019 | 33 | -56 | -56 | -50 | N/A |
3/31/2019 | 31 | -52 | -52 | -46 | N/A |
12/31/2018 | 29 | -48 | -48 | -42 | N/A |
9/30/2018 | 29 | -44 | -46 | -41 | N/A |
6/30/2018 | 29 | -40 | -45 | -40 | N/A |
3/31/2018 | 26 | -41 | -45 | -40 | N/A |
12/31/2017 | 23 | -42 | -46 | -41 | N/A |
9/30/2017 | 19 | -46 | -51 | -46 | N/A |
6/30/2017 | 14 | -50 | -56 | -50 | N/A |
3/31/2017 | 14 | -50 | N/A | -52 | N/A |
12/31/2016 | 14 | -50 | N/A | -53 | N/A |
9/30/2016 | 14 | -48 | N/A | -49 | N/A |
6/30/2016 | 14 | -47 | N/A | -44 | N/A |
3/31/2016 | 15 | -43 | N/A | -36 | N/A |
12/31/2015 | 15 | -40 | N/A | -27 | N/A |
9/30/2015 | 15 | -35 | N/A | -28 | N/A |
6/30/2015 | 15 | -30 | N/A | -28 | N/A |
3/31/2015 | 13 | -29 | N/A | -32 | N/A |
12/31/2014 | 10 | -29 | N/A | -36 | N/A |
12/31/2013 | 12 | -27 | N/A | -41 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: Insufficient data to determine if BCART's forecast earnings growth is above the savings rate (1.3%).
Winst versus markt: Insufficient data to determine if BCART's earnings are forecast to grow faster than the Belgian market
Hoge groeiwinsten: Insufficient data to determine if BCART's earnings are expected to grow significantly over the next 3 years.
Omzet versus markt: Insufficient data to determine if BCART's revenue is forecast to grow faster than the Belgian market.
Hoge groei-inkomsten: Insufficient data to determine if BCART's revenue is forecast to grow faster than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Insufficient data to determine if BCART's Return on Equity is forecast to be high in 3 years time